Conversely, diminished ANXA1 expression has been related to a poor outcome, with reduced survival rates and higher relapse incidence [38,69] in other types of cancers, e.g., thyroid carcinoma [69] and head and neck squamous cell carcinoma [70,71]. This evidence concerns the gene ANXA1 and thyroid gland carcinoma.